Targeting NPY, CRF/UCNs and NPS Neuropeptide Systems to Treat Alcohol Use Disorder (AUD).
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Targeting NPY, CRF/UCNs and NPS Neuropeptide Systems to Treat Alcohol Use Disorder (AUD).
- Published In:
- Current medicinal chemistry, 24(23), 2528-2558 (2017)
- Authors:
- Rodriguez, Francisco D, Coveñas, Rafael(2)
- Database ID:
- RPEP-03447
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-03447APA
Rodriguez, Francisco D; Coveñas, Rafael. (2017). Targeting NPY, CRF/UCNs and NPS Neuropeptide Systems to Treat Alcohol Use Disorder (AUD).. Current medicinal chemistry, 24(23), 2528-2558. https://doi.org/10.2174/0929867324666170316120836
MLA
Rodriguez, Francisco D, et al. "Targeting NPY, CRF/UCNs and NPS Neuropeptide Systems to Treat Alcohol Use Disorder (AUD).." Current medicinal chemistry, 2017. https://doi.org/10.2174/0929867324666170316120836
RethinkPeptides
RethinkPeptides Research Database. "Targeting NPY, CRF/UCNs and NPS Neuropeptide Systems to Trea..." RPEP-03447. Retrieved from https://rethinkpeptides.com/research/rodriguez-2017-targeting-npy-crfucns-and
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.